Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Alcohol-related cancers are a growing concern in India, said health experts on Monday, even as the World Health Organisation ...

LONG-term exposure to low-level traffic-derived air pollution causes liver inflammation, fibrosis, and metabolic changes ...

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Health risks caused by alcohol have received new scrutiny recently, and federal data show the annual number of drug-related ...

Interestingly, the other two common cardiometabolic risk factors—high triglycerides (a type of fat in the blood) and low HDL ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.